Anti-Human CD3 [Clone OKT-3] — Purifiedin vivoGOLD™ Functional Grade,Leinco,C2487

Host

Mouse

Reactivity

Human

Application

Depletion,FA,FC,IF

Platform ID

BAB634191976

Leinco

Headquarters

410 Axminister Drive St. Louis, Missouri 63026

Contact

Tel: +1 (800) 538-1145,+1 (636) 230-9477
Fax:

Product Specifications
Scientific Background

Specifications

NameAnti-Human CD3 [Clone OKT-3] — Purifiedin vivoGOLD™ Functional Grade
Cat. No.C2487
HostMouse
IsotypeMouse IgG2a k
ReactivityHuman
ApplicationDepletion,FA,FC,IF
Clone NumberOKT-3
Concentration≥ 5.0 mg/ml
ImmunogenHuman peripheral blood lymphocytes
Purity≥95% monomer by analytical SEC ⋅ >95% by SDS Page
Endotoxin Level< 1.0 EU/mg as determined by the LAL method
Shipping2 – 8° C Wet Ice
FormulationThis monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration.
StorageFunctional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at ≤ -70°C. Avoid Repeated Freeze Thaw Cycles.

Scientific Background

CD3 is an invariant antigen of the T cell receptor (TCR) belonging to the Ig superfamily 1 . The CD3/TCR complex is composed of a ⍺β or γδ TCR heterodimer noncovalently associated with invariant CD3 dimers εγ, εδ, and ζζ in a 1:1:1:1 stoichiometry. The TCR mediates recognition of antigenic peptides bound to major histocompatibility complex (MHC) molecules on antigen- presenting cells, while the CD3 portion of the complex transduces activation signals to the T cell nucleus. Together, TCR and CD3 molecules initiate protective immunity against microbes and cancers. OKT-3 was generated by immunizing a BALB/c or CAF1 mouse with human peripheral blood lymphocytes 2 . Spleen cells were fused with P3x63Ag8.U1 myeloma cells for hybridoma production. OKT-3 was initially developed as a pan-T cell antibody to differentiate between cell types 3 and later . became the first monoclonal antibody to be approved for therapy in humans 4 . OKT-3 acts as an immunosuppressive drug in transplant patients 5 , type 1 diabetes, and psoriasis 6 . OKT-3 recognizes, binds, and blocks the CD3 complex of the T cell receptor 4 and thereby blocks the generation and function of cytotoxic T cells 7 . The OKT-3/CD3εγ structure has been resolved 6 .

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.